3 withdrawn. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Withdrawn 3 |
Follow Vancomycin: new trials by email Literature Review of Vancomycin trials Research Report on Vancomycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prophylactic Antibiotics for Surgical Site Infections and Beta-Lactam Allergy cephalosporin, Second tier antibiotic (Vancomycin) - Surgical Site Infection, Beta-lactam Allergy | Phase 4 | Withdrawn | University of Texas Southwestern Medical Center | 2024-08-16 | 2023-12-15 | |
| Bezlotoxumab Versus FMT for Multiple Recurrent CDI Bezlotoxumab, Fecal Microbiota Transplantation (FMT), Vancomycin oral - Clostridium Infections, Clostridioides Difficile | Phase 4 | Withdrawn | Leiden University Medical Center | 2022-01-01 | 2023-03-28 | |
| Prospective Trial of Oral Vancomycin Therapy vs. Placebo for Prevention of CDI Vancomycin 125 MG po BID - CDI | Phase 4 | Withdrawn | Creighton University | 2019-10-29 | 2020-01-27 |
Clostridium Infections (1) · Enterocolitis, Pseudomembranous (1) · Surgical Wound Infection (1)
Creighton University (1) · Leiden University Medical Center (1) · University of Texas Southwestern Medical Center (1)
Netherlands (1) · United States (1)
J van Prehn (1) · Mark Haney, MD (1)